APM HUMAN SERVICES INTERNATIONAL LIMITED (APM)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

APM - APM HUMAN SERVICES INTERNATIONAL LIMITED

FNArena Sector : Healthcare
Year End: June
GICS Industry Group : Commercial Services & Supplies
Debt/EBITDA: 3.1
Index: ASX300 | ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$1.175

18 Apr
2024

-0.005

OPEN

$1.19

-0.42%

HIGH

$1.20

658,628

LOW

$1.17

TARGET
$1.60

-0.18 change from previous day

 36.2% upside
Franking for last dividend paid out: 100%
FNARENA'S MARKET CONSENSUS FORECASTS
APM: 1
Title FY22
Actual		 FY23
Actual		 FY24
Forecast		 FY25
Forecast
EPS (cps) xxx N/A 9.3 xxx
DPS (cps) xxx N/A 8.3 xxx
EPS Growth xxx N/A N/A xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A 12.7 xxx
Dividend Yield xxx N/A 7.0% xxx
Div Pay Ratio(%) xxx N/A 88.9% xxx

Dividend yield today if purchased 3 years ago: N/A

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 8.51

Estimated Dividend Growth
(Average Of Past Three Years)

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 07/09 - ex-div 5c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 20222023
EPS Basic xxx11.7
DPS All xxx10.0
Sales/Revenue xxx1,893.8 M
Book Value Per Share xxx162.5
Net Operating Cash Flow xxx153.4 M
Net Profit Margin xxx5.67 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 20222023
Return on Capital Employed xxx7.24 %
Return on Invested Capital xxx4.69 %
Return on Assets xxx3.63 %
Return on Equity xxx7.24 %
Return on Total Capital xxx8.16 %
Free Cash Flow ex dividends xxx43.2 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 20222023
Short-Term Debt xxx65 M
Long Term Debt xxx963 M
Total Debt xxx1,028 M
Goodwill - Gross xxx1,797 M
Cash & Equivalents - Generic xxx107 M
Price To Book Value xxx1.30

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 20222023
Capex xxx46.6 M
Capex % of Sales xxx2.46 %
Cost of Goods Sold xxx1,486 M
Selling, General & Admin. Exp & Other xxx216 M
Research & Development xxx-
Investments - Total xxx-

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.5

No. Of Recommendations

3
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Bell Potter

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

xx/xx/xxxx

-1

xx xxxxxx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

09/04/2024

3

Equal-weight

$1.40

19.15%

Overall employment services volumes continue to be depressed, highlights Morgan Stanley, following lower FY24 guidance by APM Human Services International.

Management now anticipates FY24 profit (UNPATA) of between $95-105m compared to the $114.5m previously expected by consensus. Prior expectations for positive 2H/4Q volume seasonality is no longer expected.

More positively, the stock is trading at a discount to private equity interest, notes Morgan Stanley. Madison Dearborn Partners has submitted a revised non-binding offer of $1.40/share.

Equal-weight rating. Target $1.40. Industry view is In-Line.

FORECAST
Morgan Stanley forecasts a full year FY24 EPS of 12.00 cents.
Morgan Stanley forecasts a full year FY25 EPS of 13.00 cents.

Ord Minnett

xx/xx/xxxx

2

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >

APM STOCK CHART

FNArena News on APM

1
Australian Broker Call *Extra* Edition – Apr 11, 2024

Apr 11 2024 - Daily Market Reports
2
Australian Broker Call *Extra* Edition – Mar 27, 2024

Mar 27 2024 - Daily Market Reports
3
Rudi’s View: CBA, GQG, Pilbara Minerals, Sonic Healthcare, Webjet & Xero

Mar 14 2024 - Rudi's View
4
FNArena Corporate Results Monitor – 29-02-2024

Feb 29 2024 - Australia
5
Rudi’s View: Week 3 – Not As Good, But Not Bad

Feb 28 2024 - Rudi's View

Latest Healthcare News

1
Dr Boreham’s Crucible: Race Oncology

Apr 09 2024 - Small Caps
2
The Power Of New Weight-Loss Drugs

Apr 03 2024 - International
3
Dr Boreham’s Crucible: Hydrix

Mar 26 2024 - Small Caps
4
Treasure Chest: Lifestyle Communities En Vogue

Mar 19 2024 - Treasure Chest
5
Uptrend Resumed For ResMed

Mar 19 2024 - Technicals
6
Capitol Health’s Higher Margin Outlook

Mar 13 2024 - Small Caps
7
Rudi’s View: Healthcare Under The Scanner

Mar 13 2024 - Rudi's View
8
Dr Boreham’s Crucible: Neuren Pharmaceuticals

Mar 11 2024 - Small Caps
9
Dr Boreham’s Crucible: Cochlear

Feb 28 2024 - Australia
10
Rudi Interviewed: Ongoing Potential In Technology & Growth

Feb 19 2024 - Rudi's View